CA
SGHT icon

Clearstead Advisors’s Sight Sciences SGHT Stock Holding History

Clearstead Advisors’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$386 Buy
+71
New +$327 ﹤0.01% 3008

Other funds holding SGHT

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AP
Americana Partners Houston, Texas $4.44B AUM 29.45% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Clearstead Advisors's SGHT Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Sight Sciences (SGHT) in Q2 2026: 71 shares worth $386. The stake represents ﹤0.01% of the portfolio and ranks #3008 among its holdings.

112 funds tracked by Wall St. Rank hold SGHT as of Q2 2026.

  • Clearstead Advisors held 71 shares of Sight Sciences worth $386 as of Q2 2026.
  • Sight Sciences was a new Clearstead Advisors position in Q2 2026.
  • Sight Sciences made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #3008 holding.
  • 112 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.